Investors
What exists, and what a first cheque funds.
PulsarOS Intelligence Inc. is a self-funded, pre-revenue federal Canadian company. Lumen is its healthcare line: the communication nervous system of a hospital. This page is written to be checked, not believed.
01 · The product
One clinician, one clone.
Every nurse and every physician gets one persistent agent, configured for that person. It owns their hospital communication and talks directly to every other clinician's clone: asking, answering, scheduling, chasing, briefing, handing over. All of it runs inside the hospital, on hardware the hospital owns.
An agent's authority is a strict subset of its human's, at every instant, on every path. A clone can never see or do anything its human could not.
Latency is the product. A communication layer slower than a corridor conversation loses to the corridor conversation.
The model never decides alone. Every clinical decision rises to a human signature.
02 · The evidence, third party and published
The failure is measured, and not by us.
of claims in a national US malpractice database involved a communication failure. A published study, presented as published.
fall in preventable adverse events when nine pediatric residency programmes adopted a structured handover protocol, across 10,740 admissions. A 2014 nine-site trial; a 2025 US patient-safety review grades the evidence at moderate certainty.
average drop in survival for each hour of antimicrobial delay after the onset of hypotension in septic shock, across the first six hours, in a large retrospective cohort of 2,731 patients. An observational association, presented as one.
Every number above belongs to published third-party studies about hospitals in general, none of them to Lumen. We publish no clinical outcome number of our own until we measure one at a reference site. The full reading of the literature is on the clinical page.
03 · The measured result
One model, two tiers, never conflated.
Quantised INT2 compression of a real 31-billion-parameter model: 58.25 GB to 5.92 GB. Lossy by design, measured and presented as lossy.
A separate result on the same model: every one of its 1188 tensors recovered bit-identical, verified per tensor with cryptographic hashes and signed provenance.
Both results were measured on reference hardware, not on the target edge silicon. Running the serving benchmark on that silicon is a funded milestone, not an assumption. The two tiers are different results and are never combined into one claim.
04 · The iron, in plain language
The hospital owns the iron.
LUMEN Core
The hospital's brain: one 8-GPU appliance in the hospital's own machine room, with keys the hospital alone controls. It holds the model, runs every clone as a live session, and roots the audit chain.
LUMEN Bedside
One per bed: a sealed, fanless, cleanable terminal that listens, transcribes, redacts, speaks and shows. Raw audio never leaves the room, because transcription and redaction happen on the device.
The PIN
One per person: a small worn credential carrying identity, presence, near-field audio and a private return path, with one physical confirm control for irreversible acts. It is the link between the clinician and their clone, not the thing they talk to.
The Lumen app
The owner's command surface: where a clinician configures their clone, checks it, and reads its full history and every interaction.
Status, stated plainly: no hardware unit has been manufactured. Every dimension, watt and millisecond attached to these elements is a computed design target derived from published silicon specifications, published as a target, never as a measurement. The hospital buys and owns its hardware through the licensed OEM channel; what scales for Lumen is the licence and the deployment, not the device.
05 · The ledger
What exists today, and what a first cheque funds.
What exists today
- 01The corrected architecture and engineering corpus, ratified and internally audited
- 02A trilingual demonstration surface (Arabic, English, French) on synthetic clinical data, with no inference backend
- 03The measured compression result above, both tiers stated separately
- 04Claim families drafted with counsel; nothing is on file anywhere
- 05A team of six, founder-grade and unpaid until funding, including an intensive care consultant as Advisory Chief Medical Officer
- 06One incorporated parent: PulsarOS Intelligence Inc., federal Canadian, Ottawa
What the first cheque funds
- 01The clinical safety, regulatory and quality hire, made first
- 02Submission of the drafted claim families
- 03The serving benchmark on the target silicon
- 04Incorporation of the Lumen operating entity before any closing, at our cost
- 05The first hospital pilot, on synthetic then consented data
Nobody on this roster has scaled a hospital vendor before, and we price that in the sequence: the clinical safety function is the first funded hire, and no pilot is signed before that function exists. The roster itself is on the about page.
06 · The structure
A Canadian parent. A Saudi subsidiary.
PulsarOS Intelligence Inc.
Federal Canadian corporation, incorporated in 2026. It holds the IP and stays the main company. The Kingdom proves it first; then it goes worldwide.
The Lumen operating entity
Builds and serves the Kingdom: an in-Kingdom engineering node doing NPHIES FHIR R4 integration, Arabic clinical voice, SFDA pathway work, and hospital deployment engineering. Incorporates before any closing.
- Kure CellsUnited States
- RebellionsSouth Korea
- OQ TechnologyLuxembourg
- PasqalFrance
- Resemble AIUnited States
- Terra DroneJapan
Six documented precedents of the same structure, no redomiciliation: each company kept its home-country parent and built a Saudi subsidiary. The closest precedent is in healthcare: Kure Cells, a US company, took a USD 10 million pre-Series A in October 2025, with the money explicitly for in-Kingdom R&D, manufacturing and adaptation to local regulatory and clinical environments.
07 · The ask
Anchoring a USD 2.4 million pre-seed. Every milestone below is funded by the anchor cheque alone.
- 01
The clinical safety, regulatory and quality hire, made first. No pilot conversation advances past an introduction without a clinical voice in the room.
- 02
The drafted claim families submitted.
- 03
The serving benchmark executed on the target silicon. It retires the assumption under every capacity figure.
- 04
The operating entity incorporated before close, at our cost. The cheque funds work, not paperwork.
- 05
The first hospital pilot signed. On synthetic then consented data. Pilot delivery is Series A scope, on a written USD 6 to 8 million ladder.
The conversation
Check it, then talk to the founder.
The demo is a trilingual demonstration surface running on synthetic clinical data. It has no inference backend, and it says so on every screen.